home
about us
member log-in
contact us

PRODUCTS
MUNICIPAL BONDS
INDEX FUNDS
- Total Asset Fund (TAF)
EVENTS
MARKET RESEARCH

Recent Quotes

View Full List

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Inovio Pharmaceuticals, Inc. - Common Stock (NQ:INO)

1.350 +0.020 (+1.50%)

Streaming Delayed Price Updated: 4:00 PM EDT, May 22, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Inovio Pharmaceuticals, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9

...

12 13 Next >

12 Health Care Stocks Moving In Friday's Intraday Session ↗

January 05, 2024

Via Benzinga

Why BlackBerry Shares Are Trading Lower By Over 5%; Here Are 20 Stocks Moving Premarket ↗

December 21, 2023

Shares of BlackBerry Limited (NYSE: BB) moved lower in pre-market trading following the release of third-quarter results.

Via Benzinga

Why GitLab Shares Are Trading Higher By Over 16%; Here Are 20 Stocks Moving Premarket ↗

December 05, 2023

Shares of GitLab Inc. (NASDAQ: GTLB) rose sharply in pre-market trading after the company posted better-than-expected results for its third quarter and issued a stro

Via Benzinga

Inovio Pharmaceuticals: Q1 Earnings Insights ↗

May 10, 2023

Via Benzinga

Why Shares of Inovio Pharmaceuticals Were Down Tuesday ↗

April 04, 2023

The biotech stock, still reeling from a failed clinical trial, hit a 52-week low.

Via The Motley Fool

Earnings Scheduled For March 1, 2023 ↗

March 01, 2023

Companies Reporting Before The Bell • Globalstar (AMEX:GSAT) is expected to report quarterly loss at $0.01 per share on revenue of $38.75 million.

Via Benzinga

The 3 Most Undervalued Biotech Stocks to Buy: November 2023 ↗

November 14, 2023

Given the undervalued biotech industry, these three undervalued biotech stocks to buy are ripe purchase targets for high-potential profits.

Via InvestorPlace

Inovio Pharmaceuticals (INO) Q3 2023 Earnings Call Transcript ↗

November 10, 2023

INO earnings call for the period ending September 30, 2023.

Via The Motley Fool

Topics Earnings

12 Health Care Stocks Moving In Friday's After-Market Session ↗

November 03, 2023

Via Benzinga

Inovio Stock Continues To Surge: What's Going On? ↗

October 11, 2023

Inovio Pharmaceuticals Inc (NASDAQ: INO) shares are trading higher again on Wednesday after surging more than 40% on Tuesday after the FDA said it can use data from the completed Phase 1/2 trial of...

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

October 10, 2023

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

October 10, 2023

Via Benzinga

Inovio Pharmaceuticals (INO) Q2 2023 Earnings Call Transcript ↗

August 09, 2023

INO earnings call for the period ending June 30, 2023.

Via The Motley Fool

Topics Earnings

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

July 05, 2023

Via Benzinga

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

June 29, 2023

Via Benzinga

INOVIO Announces Notice of Pendency and Proposed Settlement of Stockholder Derivative Actions

June 23, 2023

From Inovio Pharmaceuticals, Inc.

Via GlobeNewswire

Why 1847 Holdings Shares Are Trading Lower By Around 31%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗

July 05, 2023

Gainers Allarity Therapeutics, Inc. (NASDAQ: ALLR) shares surged 87% to $11.78 after the company said the initial data from Phase 2 trial of Ixempra shows potential for improved clinical benefit in...

Via Benzinga

Why Inovio Pharmaceuticals Shares Are Trading Higher By 12%; Here Are 20 Stocks Moving Premarket ↗

May 24, 2023

Gainers Minerva Surgical, Inc. (NASDAQ: UTRS) shares rose 202.3% to $0.5499 in pre-market trading. Minerva Surgical was granted U.S. Patent #11653972 for "Medical Systems And Methods (For Resecting And...

Via Benzinga

Inovio Pharmaceuticals (INO) Q1 2023 Earnings Call Transcript ↗

May 11, 2023

INO earnings call for the period ending March 31, 2023.

Via The Motley Fool

These 3 Nasdaq Stocks Are on Fire Today: Here's Why ↗

April 17, 2023

A high-dollar buyout is lighting a fire underneath these three Nasdaq stocks today.

Via The Motley Fool

Why Inovio Pharmaceuticals' Shares Jumped on Thursday ↗

April 13, 2023

The company will present an abstract for its Ebola vaccine booster this month.

Via The Motley Fool

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday ↗

March 10, 2023

We're starting the final day of the week with a breakdown of the biggest pre-market stock movers worth watching on Friday!

Via InvestorPlace

Inovio Pharmaceuticals (INO) Q4 2022 Earnings Call Transcript ↗

March 01, 2023

INO earnings call for the period ending December 31, 2022.

Via The Motley Fool

Stocks That Hit 52-Week Lows On Monday ↗

April 03, 2023

On Monday, 76 companies set new 52-week lows.

Via Benzinga

Why Inovio (INO) Shares Are Moving After-Hours ↗

March 01, 2023

After falling initially in after-hours trading on Wednesday, Inovio Pharmaceuticals Inc (NASDAQ: INO) shares are back up following the company report of worse-than-expected fourth-quarter financial...

Via Benzinga

2 Stocks to Sell or Remove From Your Watchlist in 2023 ↗

February 28, 2023

Both stocks soared during the coronavirus vaccine race, but their time has passed.

Via The Motley Fool

Coronavirus Vaccine Market To Surpass $95 Billion By 2028

February 28, 2023

EQNX::TICKER_START (NASDAQ:SBFM),(NASDAQ:MRNA),(NASDAQ:NVAX),(NASDAQ:VIR),(NASDAQ:INO) EQNX::TICKER_END

Via FinancialNewsMedia

Inovio Pharma Releases Favorable Data From Booster DNA Vaccine Candidate For Ebola ↗

February 02, 2023

Inovio Pharmaceuticals Inc (NASDAQ: INO) announced results from a Phase 1b trial evaluating INO-4201, a DNA vaccine candidate, as a booster in healthy adult participants who previously received a...

Via Benzinga

3 Sorry Pharma Stocks to Sell in February Before It’s Too Late ↗

February 01, 2023

These are the pharma stocks to sell, as they represent companies with weak fundamentals and sustained cash burn visibility.

Via InvestorPlace

INOVIO Announces Further Reorganization, Continues Focus on Promising DNA Candidates ↗

January 31, 2023

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 9

...

12 13 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Home
About Us
Products
Municipal Bonds
Index Funds
Seminars & Events
Market Research
Contact Us
Member Section
Privacy Policy
Terms & Conditions
Security Notice
Customer Service

Securities offered through Purshe Kaplan Sterling Investments, member FINRA / SIPC, Headquartered at 80 State Street,
Albany, NY 12207
Purshe Kaplan Sterling Investments and Tamar Securities, LLC are not affiliated companies.
Tamar Securities, LLC is a Registered Investment Adviser. Advisory services are only offered to clients or prospective clients where Tamar Securities, LLC
and its representatives are properly licensed or exempt from licensure. Past performance is no guarantee of future returns. Investing involves risk and possible loss of principal capital.
No advice may be rendered by Tamar Securities, LLC unless a client service agreement is in place.

NOT FDIC INSURED. NOT BANK GUARANTEED. MAY LOSE VALUE, INCLUDING LOSS OF PRINCIPAL. NOT INSURED BY ANY STATE OR FEDERAL AGENCY.
Web development by IBCnet.com